These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 16135498)

  • 1. Should we transplant indolent lymphoma?
    Nabhan C
    J Clin Oncol; 2005 Sep; 23(25):6263-4; author reply 6264-6. PubMed ID: 16135498
    [No Abstract]   [Full Text] [Related]  

  • 2. High frequency of unrecognized indolent hematological disorders among HLA-matched siblings of patients with lymphoproliferative malignancies eligible for allo-SCT.
    Kolstad A; Tjønnfjord G; Jønsson V
    Bone Marrow Transplant; 2008 Sep; 42(6):427-8. PubMed ID: 18587433
    [No Abstract]   [Full Text] [Related]  

  • 3. Comment to: Secondary malignancies after treatment for indolent non-Hodgkin's lymphoma: a 16-year follow-up study. Haematologica 2008; 93:398-403.
    van der Spek E; van der Griend R
    Haematologica; 2008 Jul; 93(7):e57; author reply e58. PubMed ID: 18591617
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of localized primary gastric lymphoma.
    Wöhrer S; Troch M; Raderer M
    J Clin Oncol; 2006 Jun; 24(17):2682; author reply 2682-3. PubMed ID: 16763284
    [No Abstract]   [Full Text] [Related]  

  • 5. Breast cancer following treatment of Hodgkin's disease--more reasons for less radiotherapy?
    Wolf J; Schellong G; Diehl V
    Eur J Cancer; 1997 Dec; 33(14):2293-4. PubMed ID: 9616268
    [No Abstract]   [Full Text] [Related]  

  • 6. Therapeutic radiation for lymphoma: risk of malignant mesothelioma.
    Teta MJ; Lau E; Sceurman BK; Wagner ME
    Cancer; 2007 Apr; 109(7):1432-8. PubMed ID: 17315168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Will radioimmunotherapy survive?
    Zelenetz AD
    Clin Adv Hematol Oncol; 2007 Oct; 5(10):782-4. PubMed ID: 17998896
    [No Abstract]   [Full Text] [Related]  

  • 8. Secondary malignancies after treatment for indolent non-Hodgkin's lymphoma: a 16-year follow-up study.
    Sacchi S; Marcheselli L; Bari A; Marcheselli R; Pozzi S; Luminari S; Lombardo M; Buda G; Lazzaro A; Gobbi PG; Stelitano C; Morabito F; Quarta G; Brugiatelli M
    Haematologica; 2008 Mar; 93(3):398-404. PubMed ID: 18268277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-Hodgkin lymphoma secondary to cancer chemotherapy.
    Krishnan B; Morgan GJ
    Cancer Epidemiol Biomarkers Prev; 2007 Mar; 16(3):377-80. PubMed ID: 17372233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Orbital lymphoma--a case report].
    Stan C; Samoilă O; Seceleanu A; Mihu C
    Oftalmologia; 2007; 51(1):44-8. PubMed ID: 17605271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Secondary lung tumors in hematological patients.
    Amadori D; Ronconi S
    Semin Respir Crit Care Med; 2005 Oct; 26(5):520-6. PubMed ID: 16267703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymphomas.
    Krueger H; McLean D; Williams D
    Prog Exp Tumor Res; 2008; 40():32-44. PubMed ID: 18802386
    [No Abstract]   [Full Text] [Related]  

  • 13. Relapsed non-Hodgkin lymphoma in fraternal twins managed successfully with rituximab maintenance therapy.
    Chakravarti A; Leslie WT; Venugopal P
    Clin Adv Hematol Oncol; 2005 Feb; 3(2):136-9; discussion 139-40. PubMed ID: 16166983
    [No Abstract]   [Full Text] [Related]  

  • 14. Long-term outcome and mortality trends in early-stage, Grade 1-2 follicular lymphoma treated with radiation therapy.
    Guadagnolo BA; Li S; Neuberg D; Ng A; Hua L; Silver B; Stevenson MA; Mauch P
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(3):928-34. PubMed ID: 16243446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Secondary malignancies after therapy of indolent non-Hodgkin's lymphoma.
    Friedberg JW
    Haematologica; 2008 Mar; 93(3):336-8. PubMed ID: 18310538
    [No Abstract]   [Full Text] [Related]  

  • 16. [Radiotherapy indications in non-Hodgkin lymphoma].
    Quero L; Hennequin C; Brice P
    Cancer Radiother; 2009 Oct; 13(6-7):471-8. PubMed ID: 19695926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of second malignancy after non-Hodgkin's lymphoma: a British Cohort Study.
    Mudie NY; Swerdlow AJ; Higgins CD; Smith P; Qiao Z; Hancock BW; Hoskin PJ; Linch DC
    J Clin Oncol; 2006 Apr; 24(10):1568-74. PubMed ID: 16520465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A patient with endobronchial BALT lymphoma successfully treated with radiotherapy.
    Hashemi SM; Heitbrink MA; Jiwa M; Boersma WG
    Respir Med; 2007 Oct; 101(10):2227-9. PubMed ID: 17616383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary hepatic lymphoma 1 year after resection of hepatocellular carcinoma.
    Nonami A; Takenaka K; Harada N; Kono K; Kamezaki K; Numata A; Karube K; Miyamoto T; Nagafuji K; Ohshima K; Harada M
    J Clin Oncol; 2006 Dec; 24(36):5784-6. PubMed ID: 17179113
    [No Abstract]   [Full Text] [Related]  

  • 20. Prognostic factors in indolent and aggressive lymphomas and its influence on disease outcome.
    Zodelava M; Betaneli M; Tsartsidze E; Kharabadze M
    Georgian Med News; 2009 Feb; (167):32-6. PubMed ID: 19276466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.